Literature DB >> 7791440

Polymorphisms in angiotensin-converting-enzyme gene and progression of IgA nephropathy.

P N Harden1, C Geddes, P A Rowe, J H McIlroy, M Boulton-Jones, R S Rodger, B J Junor, J D Briggs, J M Connell, A G Jardine.   

Abstract

We have investigated the influence of the functional insertion (I) and deletion (D) polymorphism in intron 16 of the gene for angiotensin-converting enzyme (ACE) in a retrospective study of 100 patients with IgA nephropathy. There was no difference in genotype frequency compared with normal subjects. However, patients homozygous for the D allele tended to present at an earlier age (medians: DD, 33; ID, 34; II, 42 years) and to require renal replacement therapy at a younger age (medians 37, 42, and 48 years, respectively). The rate of progression was significantly worse in patients homozygous for the D allele. The DD genotype is associated with increased severity of disease in patients with IgA nephropathy.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7791440     DOI: 10.1016/s0140-6736(95)91088-3

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  26 in total

1.  Association of angiotensinogen gene T235 variant with progression of immunoglobin A nephropathy in Caucasian patients.

Authors:  Y Pei; J Scholey; K Thai; M Suzuki; D Cattran
Journal:  J Clin Invest       Date:  1997-08-15       Impact factor: 14.808

2.  Examination of two genetic polymorphisms within the renin-angiotensin system: no evidence for an association with nephropathy in IDDM.

Authors:  T A Chowdhury; M J Dronsfield; S Kumar; S L Gough; S P Gibson; A Khatoon; F MacDonald; B R Rowe; D B Dunger; J D Dean; S J Davies; J Webber; P R Smith; P Mackin; S M Marshall; D Adu; P J Morris; J A Todd; A H Barnett; A J Boulton; S C Bain
Journal:  Diabetologia       Date:  1996-09       Impact factor: 10.122

3.  Deletion polymorphism of the angiotensin converting enzyme gene predicts persistent proteinuria in Henoch-Schönlein purpura nephritis.

Authors:  T Yoshioka; Y X Xu; H Yoshida; H Shiraga; T Muraki; K Ito
Journal:  Arch Dis Child       Date:  1998-11       Impact factor: 3.791

Review 4.  [ACE gene polymorphism and cardiovascular diseases].

Authors:  B Mayer; H Schunkert
Journal:  Herz       Date:  2000-02       Impact factor: 1.443

5.  Unexpected kidney-restricted role for IL-17 receptor signaling in defense against systemic Candida albicans infection.

Authors:  Kritika Ramani; Chetan V Jawale; Akash H Verma; Bianca M Coleman; Jay K Kolls; Partha S Biswas
Journal:  JCI Insight       Date:  2018-05-03

6.  Renin-angiotensin system polymorphisms and renal scarring.

Authors:  Rafael Pardo; Serafín Málaga; Eliecer Coto; Mercedes Navarro; Victoria Alvarez; Laura Espinosa; Ruth Alvarez; Alfredo Vallo; Cesar Loris; Socorro Braga
Journal:  Pediatr Nephrol       Date:  2002-12-19       Impact factor: 3.714

7.  Genetical, histological, and clinical characteristics of IgA-negative mesangioproliferative glomerulopathy.

Authors:  Kazunori Owada; Hodaka Suzuki; Tetsuo Katoh; Tsuyoshi Watanabe
Journal:  Clin Exp Nephrol       Date:  2009-11-25       Impact factor: 2.801

8.  Association of angiotensin-converting enzyme and endothelial Nitric Oxide synthase gene polymorphisms with vascular disease in ESRD patients in a Chinese population.

Authors:  Feng-Ying Tang; Fu-You Liu; Xiong-Wei Xie
Journal:  Mol Cell Biochem       Date:  2008-07-16       Impact factor: 3.396

9.  Impact of the preintervention rate of renal function decline on outcome of renoprotective intervention.

Authors:  A Titia Lely; Frank G H van der Kleij; Taco J Kistemaker; Alfred J Apperloo; Paul E de Jong; Dick de Zeeuw; Gerjan Navis
Journal:  Clin J Am Soc Nephrol       Date:  2007-12-12       Impact factor: 8.237

10.  A scoring system to predict renal outcome in IgA nephropathy: a nationwide 10-year prospective cohort study.

Authors:  Masashi Goto; Kenji Wakai; Takashi Kawamura; Masahiko Ando; Masayuki Endoh; Yasuhiko Tomino
Journal:  Nephrol Dial Transplant       Date:  2009-06-10       Impact factor: 5.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.